Quantitative low-volume assay for simultaneous determination of fentanyl, norfentanyl, and minor metabolites in human plasma and urine by liquid chromatography—tandem mass spectrometry (LC-MS/MS)
- 6 July 2014
- journal article
- Published by Springer Nature in International journal of legal medicine
- Vol. 128 (5) , 771-778
Abstract
A rapid and sensitive liquid chromatography/tandem mass spectrometric (LC-MS/MS) method for simultaneous quantification of fentanyl (F), norfentanyl (NF), despropionylfentanyl (DPF), and hydroxynorfentanyl (OHNF) in human plasma and urine specimens has been developed and validated according to international guidelines. Analytes were extracted from 250-μL plasma or urine by liquid–liquid extraction. OHNF in urine affords a second extraction step and analysis with a different column. Calibration curves in plasma were linear from 0.05–10 ng/mL for F, 0.07–0.5 ng/mL for NF, 0.02–1.0 ng/ml for DPF, and 0.67–3.0 ng/mL for OHNF; in urine, from 0.09–10.0, 0.17–50, 0.08–1.0, and 1.0–5.0 ng/mL for F, NF, DPF, and OHNF, respectively. Analytical bias and intra- and inter-assay imprecision were within ±15 % of target, except for OHNF in plasma and DPF in urine at the respective lower quality control level. All analytes were stable in processed samples when stored for 24 h at room temperature. Recoveries and process efficiencies were above 82.9 and 75.1 % for all analytes in plasma and urine. The low level of DPF in plasma indicated with a matrix effect of 71.3 % moderate ion suppression, all other analytes in plasma and urine showed no matrix effects. The lower limit of quantification (LOQ) in plasma was 0.05, 0.07, 0.02 and 0.67 ng/mL for F, NF, DPF, and OHNF, respectively. In urine, the LOQ of F, NF, DPF, and OHNF were 0.09, 0.17, 0.08, and 1.28 ng/mL, respectively. This assay has been applied to human specimens collected during a clinical drug–drug interaction study.Keywords
This publication has 39 references indexed in Scilit:
- Fentanyl: Toxic or Therapeutic? Postmortem and Antemortem Blood Concentrations After Transdermal Fentanyl ApplicationJournal of Analytical Toxicology, 2012
- The use ofin vitrotechnologies coupled with high resolution accurate mass LC‐MS for studying drug metabolism in equine drug surveillanceDrug Testing and Analysis, 2010
- Report of a patient chewing fentanyl patches who was titrated onto methadoneBMJ Case Reports, 2009
- Development of a liquid chromatography–isotope dilution mass spectrometry method for quantification of fentanyl in human plasmaBiomedical Chromatography, 2009
- Fatalities Associated with Fentanyl and Co‐administered Cocaine or OpiatesJournal of Forensic Sciences, 2007
- Determination of fentanyl in human plasma and fentanyl and norfentanyl in human urine using LC–MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2005
- Analysis of amphetamines and fentanyls by atmospheric pressure desorption/ionization on silicon mass spectrometry and matrix‐assisted laser desorption/ionization mass spectrometry and its application to forensic analysis of drug seizuresJournal of Mass Spectrometry, 2005
- High Performance Liquid Chromatography Microassay for the Simultaneous Determination of Fentanyl and Its Major Metabolites in Biological SamplesJournal of Liquid Chromatography & Related Technologies, 1996
- Identification and Quantitative Determination of Fentanyl Metabolites in Patients by Gas Chromatography-Mass SpectrometryAnesthesiology, 1984
- STUDIES ON THE FATE OF FENTANYLThe Keio Journal of Medicine, 1969